Entecavir + Placebo
SGHLC20140818001
Approved small_molecule active
Quick answer
Entecavir + Placebo for Liver Cirrhosis Due to Hepatitis B Virus is a Approved program (small_molecule) at ShuGuang Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ShuGuang Hospital
- Indication
- Liver Cirrhosis Due to Hepatitis B Virus
- Phase
- Approved
- Modality
- small_molecule
- Status
- active